AlphAIalphai — Financial news for AI agents
SEC EDGARJUL 162 min read$AI

SIEBEL THOMAS M sold $4.2M of AI

SIEBEL THOMAS M (CEO and Chairman of the Board) sold 462,565 shares of C3.ai, Inc. (AI) at an average of $9.18 ($9.07–$9.32, $4.24M total) across 3 trades over 2026-07-14 to 2026-07-15 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · SIEBEL THOMAS M
Published Jul 16, 2026, 4:00 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 6, 2026, 8:17 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
alphai market briefInsider activity
Primary signal
$AI
Neutral
medium confidence
Mentioned
$AI
Relevance
5/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$AINeutralLow
01

Why it matters

Insider sales can influence sentiment, but 10b5-1 pre-arranged plans typically reduce interpretability as new negative information.

02

Market read

A disclosed insider sale of about $4.24M under a 10b5-1 plan is unlikely to drive a major repricing by itself.

03

What to watch

Traders may over-weight the sale without considering the CEO’s remaining holdings (722,362 shares after the transaction) and the multi-trade execution window.

Relevance 5/10Novelty 3/10Timing: Filed on 2026-07-16 for sales executed 2026-07-14 to 2026-07-15.

Background

The article is an SEC Form 4 insider transaction disclosure for C3.ai, Inc. (AI).

Company-level read

Ticker impact

$AINeutralMedium confidence
Context

C3.ai CEO and Chairman sold 462,565 shares in open-market trades for about $4.24M under a pre-arranged 10b5-1 plan.

Expected impact

Likely limited, short-lived impact unless accompanied by other company-specific news.

Evidence & confidence

Form 4 shows a pre-arranged 10b5-1 plan and a relatively small absolute value versus typical large-cap trading, which usually dampens signal strength.

Market effects

Sector

No clear sector read-through; this is company-specific insider activity.

Regional

None indicated.

Global

None indicated.

Counterpoint

What could challenge this read

Because the trades were executed under a pre-arranged 10b5-1 plan, the sale may be purely planned liquidity rather than a bearish signal.

Key entities

  • issuer
    C3.ai, Inc.

    Subject of the Form 4 insider sale by its CEO and Chairman.

  • insider
    SIEBEL THOMAS M

    CEO and Chairman of the Board who sold shares under a 10b5-1 plan.

Read at source← All news

Related articles

JUL 8
$AIMed

Trump Family Pockets Half A Billion As Trump-Backed Crypto Firm Moves To Sell Only Revenue-Generating Business

The Wall Street Journal reports Nasdaq-listed AI Financial (formerly Alt5 Sigma) is in talks to sell its only revenue-generating payments subsidiary to Tokyo-based Perpetuals.com for up to $15 million. The unit generated about $25 million revenue in 2024. AI Financial’s losses followed World Liberty’s August 2025 WLFI token purchase and WLFI’s ~70% decline, with AI Financial reporting a $271 million quarterly loss.

ibtimes.com6 min
JUN 4
$AIMedAI 9/10

C3.ai Q4 2026 Earnings Call Transcript - C3.ai (NYSE:AI)

C3.ai held its Q4 earnings call, reporting total revenue of $51.6 million, with subscription revenue 94% of the total. The company said it cut headcount about 35% and expects ~$135 million in annual operating cost savings. CEO Tom Siebel cited poor sales execution and plans to expand its target accounts. FY2027 guidance calls for $210–$240 million revenue and non-GAAP operating loss of $128–$160 million.

benzinga.com6 min
JUN 3
$AIHighAI 9/10

Live: Will C3.ai Beat Q4 Earnings After the Bell Tonight?

C3.ai (AI) reports Q4 fiscal 2026 results after the close. The company is focused on revenue within guidance ($48.0M–$52.0M), improving GAAP gross margin from 17% (down from 59% a year earlier), and expanding federal bookings, which rose 134% YoY to 55% of total bookings. Wall Street has 6 sell and 7 hold ratings; average target is $8.82 vs. $10.51.

247wallst.com4 min
MAY 30
$AIMedAI 8/10

Wall Street Has a Consensus on This AI Stock. The Consensus Is Dead Wrong.

The article argues that Wall Street’s consensus on C3.ai (AI) is inconsistent and may not reflect deteriorating fundamentals. It cites a hold consensus from 12 analysts with an average price target near $17 versus a stock price around $9.50. For fiscal Q1 2026 ended July 31, C3.ai reported about $50M revenue, missed guidance, posted a $0.40 loss per share vs $0.30 estimate, and guided continued pressure.

fool.com6 min
MAY 25
$AIMedAI 9/10

Thomas Siebel Is Back as C3.ai CEO. Will This Help the Stock Rebound?

C3.ai shares are down 59% over 12 months as the company’s sales have declined, despite having 100+ enterprise AI turnkey solutions. After CEO/founder Thomas Siebel stepped down in 2024 for health reasons and Stephen Ehikian took over Sept. 1, 2025, C3.ai reported preliminary Q4 revenue of $51.6M vs. $108.7M a year earlier. The company says Siebel returned as CEO May 8.

fool.com3 min